Venous thromboembolism in patients with heart failure

被引：0

作者：

Averkov, O. V. ^{[1
]}

Shevchenko, I. V. ^{[1
]}

Mirilashvili, T. Sh. ^{[1
]}

Kobalava, Zh. D. ^{[1
]}

机构：

[1] Russian Univ Peoples Friendship, City Clin Hosp 64, Moscow, Russia

来源：

CARDIOVASCULAR THERAPY AND PREVENTION | 2011年 / 10卷 / 04期

关键词：

Venous thromboembolism; pulmonary artery thromboembolism; heart failure; low molecular weight heparin; unfractionated heparin; Factor Xa inhibitors; DEEP-VEIN THROMBOSIS; ILL MEDICAL PATIENTS; PULMONARY-EMBOLISM; RISK-FACTORS; TASK-FORCE; PREVENTION; PROPHYLAXIS; THROMBOPROPHYLAXIS; GUIDELINES; MORTALITY;

D O I：

10.15829/1728-8800-2011-4-101-106

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This review is focussed on the problem of venous thromboembolism in patients with heart failure (H F). The results of the major clinical trials of antithrombotic therapy in HF patients are presented. The authors discuss comparative effectiveness, safety, and tolerability of unfractionated heparins, low molecular weight heparins, and fondaparinux. The results of the two trials, MAGELLAN and ADOPT, are expected to clarify the clinical potential of such oral anticoagulants as rivaroxaban and apixaban (Factor Xa inhibitors). The problem of low rates e of preventive antithrombotic administration is emphasized.

引用

页码：101 / 106

页数：6

共 42 条

[1]

Ageno W, 2002, HAEMATOLOGICA, V87, P746

[2] Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure [J].

Alehagen, U ;

Dahlström, U ;

Lindahl, TL .

THROMBOSIS AND HAEMOSTASIS, 2004, 92 (06) :1250-1258

[3] Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study [J].

Alikhan, R ;

Cohen, AT ;

Combe, S ;

Samama, MM ;

Desjardins, L ;

Eldor, A ;

Janbon, C ;

Leizorovicz, A ;

Olsson, CG ;

Turpie, AGG .

BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (04) :341-346

[4] Epidemiology of Venous Thromboembolism in Cardiorespiratory and Infectious Disease [J].

Alikhan, Raza ;

Spyropoulos, Alex C. .

AMERICAN JOURNAL OF MEDICINE, 2008, 121 (11) :935-942

[5] Examining the rate of appropriate, ACCP-recommended VTE prophylaxis use in heart failure patients [J].

Amin, Alpesh N. ;

Lin, Jay ;

Yang, Guiping ;

Stemkowski, Steven .

JOURNAL OF CARDIAC FAILURE, 2008, 14 (06) :S83-S83

[6] Mortality trends for 23,505 Medicare patients hospitalized with heart failure in Northeast Ohio, 1991 to 1997 [J].

Baker, DW ;

Einstadter, D ;

Thomas, C ;

Cebul, RD .

AMERICAN HEART JOURNAL, 2003, 146 (02) :258-264

[7] Risk of venous thromboembolism in. patients hospitalized with heart failure [J].

Beemath, Afzal ;

Stein, Paul D. ;

Skaf, Elias ;

Al Sibae, M. Rasm ;

Alesh, Issa .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (06) :793-795

[8] Thromboprophylaxis with dalteparin in medical patients: which patients benefit? [J].

Cohen, Alexander T. ;

Turpie, Alexander G. G. ;

Leizorovicz, Alain ;

Olsson, Carl-Gustav ;

Vaitkus, Paul T. ;

Goldhaber, Samuel Z. .

VASCULAR MEDICINE, 2007, 12 (02) :123-127

[9] Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial [J].

Cohen, AT ;

Davidson, BL ;

Gallus, AS ;

Lassen, MR ;

Prins, MH ;

Tomkowski, W ;

Turpie, AGG ;

Egberts, JFM ;

Lensing, AWA .

BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7537) :325-327

[10] Acute pulmonary embolism is an independent predictor of adverse events in severe decompensated heart failure patients [J].

Darze, Eduardo S. ;

Latado, Adriana L. ;

Guimaraes, Aloyra G. ;

Guedes, Rodrigo A. V. ;

Santos, Alessandra B. ;

de Moura, Simone S. ;

Santana Passos, Luiz Carlos .

CHEST, 2007, 131 (06) :1838-1843

← 1 2 3 4 5 →